IP Library › Patent Application 15923470
Patent Application
App. No. 15/923,470

TREATMENT OF MYELOSUPPRESSION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/923,470
Abstract

Methods are presented for attenuating myelosuppressive side effects of treatment regimens, promoting thrombopoiesis and neutrophil production, and increasing efficacy of treatment regimens, by administering PF4-interacting heparinoids.

Claims (2)

1 . A method of attenuating a myelosuppressive side effect of a patient treatment regimen comprising:

adjunctively administering a therapeutically effective amount of a PF4-interacting heparinoid to the patient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2018
From: MARCUS, STEPHEN
To: CANTEX PHARMACEUTICALS, INC.
Reel/Frame 046442/0997 →